Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Apr;27(4):648–649. doi: 10.1128/aac.27.4.648

Once-daily ceftriaxone for skin and soft tissue infections.

F M Gordin, C B Wofsy, J Mills
PMCID: PMC180114  PMID: 4004197

Abstract

We prospectively compared once-daily administration of ceftriaxone with cefazolin given every 8 h for the treatment of skin and soft tissue infections. Thirty-one patients received cefazolin for a mean of 4.5 days, and 26 patients received ceftriaxone for a mean of 4.0 days. All patients had a satisfactory response. Adverse reactions were few and reversible. Ceftriaxone given as a single daily intramuscular injection is effective therapy for skin and soft tissue infections.

Full text

PDF
648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dudley M., Barriere S., Mills J. Cost comparisons among antimicrobial agents. N Engl J Med. 1982 Sep 9;307(11):689–689. doi: 10.1056/NEJM198209093071120. [DOI] [PubMed] [Google Scholar]
  2. Eickhoff T. C., Ehret J. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother. 1981 Mar;19(3):435–442. doi: 10.1128/aac.19.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Maslow M. J., Levine J. F., Pollock A. A., Simberkoff M. S., Rahal J. J., Jr Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections. Antimicrob Agents Chemother. 1982 Jul;22(1):103–107. doi: 10.1128/aac.22.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mills J., Slutkin G., Klein D., Schecter W. Ceftizoxime compared with cefamandole for treatment of soft tissue infections. J Antimicrob Chemother. 1982 Nov;10 (Suppl 100):273–279. doi: 10.1093/jac/10.suppl_c.273. [DOI] [PubMed] [Google Scholar]
  5. Neu H. C., Meropol N. J., Fu K. P. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother. 1981 Mar;19(3):414–423. doi: 10.1128/aac.19.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Patel I. H., Weinfeld R. E., Konikoff J., Parsonnet M. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents. Antimicrob Agents Chemother. 1982 Jun;21(6):957–962. doi: 10.1128/aac.21.6.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Poretz D. M., Eron L. J., Goldenberg R. I., Gilbert A. F., Rising J., Sparks S., Horn C. E. Intravenous antibiotic therapy in an outpatient setting. JAMA. 1982 Jul 16;248(3):336–339. [PubMed] [Google Scholar]
  8. Rehm S. J., Weinstein A. J. Home intravenous antibiotic therapy: a team approach. Ann Intern Med. 1983 Sep;99(3):388–392. doi: 10.7326/0003-4819-99-3-388. [DOI] [PubMed] [Google Scholar]
  9. Webb D., Thadepalli H. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs. West J Med. 1979 Mar;130(3):200–204. [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES